Clinical Trials Browser

Uterine Cervical Dysplasia × Antigens × Clear all

NCT02576561 2017-10-25

Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL

Phase 2 Unknown

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia